Arteriosclerosis, Vol 4, 256-264, Copyright © 1984 by American Heart Association

ARTICLES

In vivo catabolism of biologically modified LDL

JF Nagelkerke, L Havekes, VW van Hinsbergh and TJ van Berkel

Incubation of human low density lipoprotein (LDL) at 37 degrees C in the presence of human umbilical vein endothelial cells (EC) caused a time-dependent shift in the charge and density of LDL. The physical changes of the human LDL occurred parallel with an increase in its clearance from the serum and uptake in the liver when injected into rats. The serum decay of the EC-modified LDL (44 hours incubation) was 20 times faster than for control LDL. EC-modified LDL, cleared from the blood, was quantitatively recovered in the liver. Isolation of the different liver cell types (parenchymal, Kupffer, and endothelial cells) after in vivo injection of 125I-EC-modified LDL showed that approximately 30 times more radioactivity was associated with the endothelial cells than with the parenchymal cells (per milligram of cell protein). In vitro experiments indicated that EC-modified-LDL was processed by the rat liver endothelial cells via a high affinity, saturable pathway related to the pathway by which these cells processed acetyl-LDL. We concluded that, if EC-modified LDL is generated in vivo, the liver, and in particular the endothelial cells, forms the major protection system against the occurrence of atherogenic particles in the blood.

This article has been cited by other articles:

				M. BEDNARSKA-MAKARUK, M. RODO, C. MARKUSZEWSKI, A. ROZENFELD, M. SWIDERSKA, B. HABRAT, and H. WEHR POLYMORPHISMS OF APOLIPOPROTEIN E AND ANGIOTENSIN-CONVERTING ENZYME GENES AND CAROTID ATHEROSCLEROSIS IN HEAVY DRINKERS Alcohol Alcohol., July 1, 2005; 40(4): 274 - 282. [Abstract] [Full Text] [PDF]

				P A Gordon, J George, M A Khamashta, D Harats, G Hughes, and Y Shoenfeld Atherosclerosis and autoimmunity Lupus, April 1, 2001; 10(4): 249 - 252. [Abstract] [PDF]

				K Kostner, S Hornykewycz, P Yang, T Neunteufl, D Glogar, F Weidinger, G Maurer, and K Huber Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls Cardiovasc Res, December 1, 1997; 36(3): 330 - 336. [Abstract] [Full Text] [PDF]

				K. E. Matthys, C. E. Van Hove, M. M. Kockx, L. J. Andries, N. Van Osselaer, A. G. Herman, and H. Bult Local Application of LDL Promotes Intimal Thickening in the Collared Carotid Artery of the Rabbit Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2423 - 2429. [Abstract] [Full Text]

				E. C. Tozer and T. E. Carew Residence Time of Low-Density Lipoprotein in the Normal and Atherosclerotic Rabbit Aorta Circ. Res., February 1, 1997; 80(2): 208 - 218. [Abstract] [Full Text]

				S. Rangaswamy, M. S. Penn, G. M. Saidel, and G. M. Chisolm Exogenous Oxidized Low-Density Lipoprotein Injures and Alters the Barrier Function of Endothelium in Rats In Vivo Circ. Res., January 1, 1997; 80(1): 37 - 44. [Abstract] [Full Text]

				K. Juul, L. B. Nielsen, K. Munkholm, S. Stender, and B. G. Nordestgaard Oxidation of Plasma Low-Density Lipoprotein Accelerates Its Accumulation and Degradation in the Arterial Wall In Vivo Circulation, October 1, 1996; 94(7): 1698 - 1704. [Abstract] [Full Text]

				D. M. Shih, Y.-R. Xia, X.-P. Wang, E. Miller, L. W. Castellani, G. Subbanagounder, H. Cheroutre, K. F. Faull, J. A. Berliner, J. L. Witztum, et al. Combined Serum Paraoxonase Knockout/Apolipoprotein E Knockout Mice Exhibit Increased Lipoprotein Oxidation and Atherosclerosis J. Biol. Chem., June 2, 2000; 275(23): 17527 - 17535. [Abstract] [Full Text] [PDF]